• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

理解微生物组在癌症治疗创新中的机制和转化意义。

Understanding the mechanisms and translational implications of the microbiome for cancer therapy innovation.

机构信息

Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Cancer Immunology Program, Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

出版信息

Nat Cancer. 2023 Aug;4(8):1083-1094. doi: 10.1038/s43018-023-00602-2. Epub 2023 Jul 31.

DOI:10.1038/s43018-023-00602-2
PMID:37525016
Abstract

The intersection of the microbiota and cancer and the mechanisms that define these interactions are a fascinating, rapidly evolving area of cancer biology and therapeutics. Here we present recent insights into the mechanisms by which specific bacteria or their communities contribute to carcinogenesis and discuss the bidirectional interplay between microbiota and host gene or epigenome signaling. We conclude with comments on manipulation of the microbiota for the therapeutic benefit of patients with cancer.

摘要

微生物组与癌症的交汇点以及定义这些相互作用的机制是癌症生物学和治疗学中一个引人入胜且快速发展的领域。在这里,我们介绍了最近对特定细菌或其群落促进癌变的机制的深入了解,并讨论了微生物组与宿主基因或表观基因组信号之间的双向相互作用。最后,我们对操纵微生物组以造福癌症患者的治疗益处发表了评论。

相似文献

1
Understanding the mechanisms and translational implications of the microbiome for cancer therapy innovation.理解微生物组在癌症治疗创新中的机制和转化意义。
Nat Cancer. 2023 Aug;4(8):1083-1094. doi: 10.1038/s43018-023-00602-2. Epub 2023 Jul 31.
2
Relevance of tumor microbiome in cancer incidence, prognosis, and its clinical implications in therapeutics.肿瘤微生物组与癌症发病机制、预后的相关性及其在治疗学中的临床意义。
Biochim Biophys Acta Rev Cancer. 2023 Sep;1878(5):188956. doi: 10.1016/j.bbcan.2023.188956. Epub 2023 Jul 19.
3
The Microbiome Matters: Its Impact on Cancer Development and Therapeutic Responses.微生物组至关重要:其对癌症发展和治疗反应的影响。
J Microbiol. 2024 Mar;62(3):137-152. doi: 10.1007/s12275-024-00110-7. Epub 2024 Apr 8.
4
Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential.微生物组与结直肠癌:在癌变过程中的作用及临床潜力。
Mol Aspects Med. 2019 Oct;69:93-106. doi: 10.1016/j.mam.2019.05.001. Epub 2019 May 24.
5
Microbiota in cancer development and treatment.癌症发展与治疗中的微生物组。
J Cancer Res Clin Oncol. 2019 Jan;145(1):49-63. doi: 10.1007/s00432-018-2816-0. Epub 2018 Dec 12.
6
Microbiome in Colonic Carcinogenesis.肠道微生物组与结直肠癌的发生
Compr Physiol. 2023 Jun 26;13(3):4685-4708. doi: 10.1002/cphy.c210052.
7
Potential role of intratumor bacteria outside the gastrointestinal tract: More than passengers.肿瘤内消化道外细菌的潜在作用:不止是过客。
Cancer Med. 2023 Aug;12(16):16756-16773. doi: 10.1002/cam4.6298. Epub 2023 Jun 28.
8
Engineering commensal bacteria to rewire host-microbiome interactions.工程共生菌以重新连接宿主-微生物组相互作用。
Curr Opin Biotechnol. 2020 Apr;62:116-122. doi: 10.1016/j.copbio.2019.09.007. Epub 2019 Oct 22.
9
Role of the intratumoral microbiome in tumor progression and therapeutics implications.肿瘤内微生物群在肿瘤进展及治疗意义中的作用。
Biochim Biophys Acta Rev Cancer. 2023 Nov;1878(6):189014. doi: 10.1016/j.bbcan.2023.189014. Epub 2023 Oct 31.
10
Airway Microbiota as a Modulator of Lung Cancer.气道微生物群作为肺癌的调节因子
Int J Mol Sci. 2020 Apr 26;21(9):3044. doi: 10.3390/ijms21093044.

引用本文的文献

1
Molecular Mechanisms of Probiotic Action Against Gastrointestinal Cancers.益生菌抗胃肠道癌症作用的分子机制
Int J Mol Sci. 2025 Aug 14;26(16):7857. doi: 10.3390/ijms26167857.
2
Gut-Vaginal Microbiome Crosstalk in Ovarian Cancer: Implications for Early Diagnosis.卵巢癌中的肠道-阴道微生物群串扰:对早期诊断的意义
Pathogens. 2025 Jun 25;14(7):635. doi: 10.3390/pathogens14070635.
3
Genetic evidence for causal links between diet, gut microbiota, and hepatobiliary cancer: a Mendelian randomization study.饮食、肠道微生物群与肝胆癌之间因果关系的遗传证据:一项孟德尔随机化研究。

本文引用的文献

1
Conversion of unresponsiveness to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma: study protocol for a randomized phase Ib/IIa trial.粪便微生物移植使转移性黑色素瘤患者对免疫检查点抑制无应答转化:一项随机 I 期/IIa 期试验的研究方案。
BMC Cancer. 2022 Dec 30;22(1):1366. doi: 10.1186/s12885-022-10457-y.
2
Targeting the gut microbiota for cancer therapy.以肠道微生物群为靶点进行癌症治疗。
Nat Rev Cancer. 2022 Dec;22(12):703-722. doi: 10.1038/s41568-022-00513-x. Epub 2022 Oct 17.
3
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases.
AMB Express. 2025 Jul 4;15(1):100. doi: 10.1186/s13568-025-01910-9.
4
Locally producing antibacterial peptide to deplete intratumoral pathogen for preventing metastatic breast cancer.局部产生抗菌肽以清除肿瘤内病原体预防转移性乳腺癌。
Acta Pharm Sin B. 2025 Feb;15(2):1084-1097. doi: 10.1016/j.apsb.2025.01.002. Epub 2025 Jan 10.
5
HMGA1 acts as an epigenetic gatekeeper of ASCL2 and Wnt signaling during colon tumorigenesis.在结肠癌发生过程中,HMGA1作为ASCL2和Wnt信号通路的表观遗传守门人。
J Clin Invest. 2025 Feb 3;135(3):e184442. doi: 10.1172/JCI184442.
6
Fecal microbial transplants as investigative tools in cancer.粪便微生物移植作为癌症研究工具。
Am J Physiol Gastrointest Liver Physiol. 2024 Nov 1;327(5):G711-G726. doi: 10.1152/ajpgi.00171.2024. Epub 2024 Sep 20.
7
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets.肿瘤起始与早期癌变:分子机制与干预靶点。
Signal Transduct Target Ther. 2024 Jun 19;9(1):149. doi: 10.1038/s41392-024-01848-7.
8
EPA, DHA, and resolvin effects on cancer risk: The underexplored mechanisms.EPA、DHA 和 resolvin 对癌症风险的影响:未充分探索的机制。
Prostaglandins Other Lipid Mediat. 2024 Oct;174:106854. doi: 10.1016/j.prostaglandins.2024.106854. Epub 2024 May 31.
9
An emerging strategy: probiotics enhance the effectiveness of tumor immunotherapy via mediating the gut microbiome.一种新兴策略:益生菌通过调节肠道微生物组来增强肿瘤免疫疗法的效果。
Gut Microbes. 2024 Jan-Dec;16(1):2341717. doi: 10.1080/19490976.2024.2341717. Epub 2024 May 8.
10
Microbiome and Prostate Cancer: Emerging Diagnostic and Therapeutic Opportunities.微生物组与前列腺癌:新出现的诊断和治疗机遇
Pharmaceuticals (Basel). 2024 Jan 13;17(1):112. doi: 10.3390/ph17010112.
不同疾病的粪便微生物群移植后定植的菌株变异性和微生物组组成的可预测性。
Nat Med. 2022 Sep;28(9):1913-1923. doi: 10.1038/s41591-022-01964-3. Epub 2022 Sep 15.
4
Identification of clinical and ecological determinants of strain engraftment after fecal microbiota transplantation using metagenomics.使用宏基因组学鉴定粪便微生物群移植后菌株定植的临床和生态决定因素。
Cell Rep Med. 2022 Aug 16;3(8):100711. doi: 10.1016/j.xcrm.2022.100711. Epub 2022 Aug 4.
5
Colon Tumors in Enterotoxigenic Bacteroides fragilis (ETBF)-Colonized Mice Do Not Display a Unique Mutational Signature but Instead Possess Host-Dependent Alterations in the APC Gene.产肠毒素脆弱拟杆菌(ETBF)定植小鼠的结肠肿瘤未显示独特的突变特征,而是 APC 基因具有宿主依赖性改变。
Microbiol Spectr. 2022 Jun 29;10(3):e0105522. doi: 10.1128/spectrum.01055-22. Epub 2022 May 19.
6
Identification of shared and disease-specific host gene-microbiome associations across human diseases using multi-omic integration.利用多组学整合技术鉴定人类疾病中共享和疾病特异性的宿主基因-微生物组关联。
Nat Microbiol. 2022 Jun;7(6):780-795. doi: 10.1038/s41564-022-01121-z. Epub 2022 May 16.
7
β-Hydroxybutyrate suppresses colorectal cancer.β-羟丁酸抑制结直肠癌。
Nature. 2022 May;605(7908):160-165. doi: 10.1038/s41586-022-04649-6. Epub 2022 Apr 27.
8
Effect of Helicobacter pylori Eradication on Gastric Cancer Prevention: Updated Report From a Randomized Controlled Trial With 26.5 Years of Follow-up.幽门螺杆菌根除对胃癌预防的影响:一项 26.5 年随访的随机对照试验的更新报告。
Gastroenterology. 2022 Jul;163(1):154-162.e3. doi: 10.1053/j.gastro.2022.03.039. Epub 2022 Mar 29.
9
in Health and Disease.在健康与疾病方面。
Microorganisms. 2022 Feb 28;10(3):522. doi: 10.3390/microorganisms10030522.
10
Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis.肠道微生物衍生胆汁酸在肠道免疫、炎症和肿瘤发生中的作用。
Cell Host Microbe. 2022 Mar 9;30(3):289-300. doi: 10.1016/j.chom.2022.02.004.